In Silico Molecular Modeling and Docking in Drug Development
Live Registration
BATCH #24
03Seats Left
92% Booked
02
Days
:
00
Hrs
:
00
Min
:
00
Sec
Course Overview
In silico molecular modeling and docking play a crucial role in modern drug discovery and development by enabling the prediction and analysis of molecular interactions between drug candidates and their biological targets. This computational drug design course covers both the theoretical foundations and practical applications of these techniques, focusing on molecular dynamics simulations, binding site identification, virtual screening, and structure-based drug design (SBDD).
Participants will learn to use various molecular docking software and biological databases to perform ligand-receptor docking studies, structure validation, and binding affinity estimation. Emphasis is placed on using tools like PyRx, ArgusLab, and ChemSketch to simulate real-world drug discovery pipelines.
Through hands-on sessions and projects, participants will gain experience in lead optimization, QSAR modeling, and energy minimization techniques—making them proficient in computational workflows commonly used in pharmaceutical R&D and biotechnology innovation.
Program Syllabus
Module 1
About This Course
In silico molecular modeling and docking play a crucial role in modern drug discovery and development by enabling the prediction and analysis of molecular interactions between drug candidates and their biological targets. This computational drug design course covers both the theoretical foundations and practical applications of these techniques, focusing on molecular dynamics simulations, binding site identification, virtual screening, and structure-based drug design (SBDD).
Participants will learn to use various molecular docking software and biological databases to perform ligand-receptor docking studies, structure validation, and binding affinity estimation. Emphasis is placed on using tools like PyRx, ArgusLab, and ChemSketch to simulate real-world drug discovery pipelines.
Through hands-on sessions and projects, participants will gain experience in lead optimization, QSAR modeling, and energy minimization techniques—making them proficient in computational workflows commonly used in pharmaceutical R&D and biotechnology innovation.
Module 2
Aim
The program aims to equip participants with comprehensive knowledge and practical experience in in silico drug design methods including ligand-based drug design (LBDD), homology modeling, and molecular interaction studies. It prepares learners to accelerate the hit-to-lead process and perform AI-driven drug candidate optimization using virtual screening strategies.
Module 3
Program Objectives
- Understand the principles of molecular modeling and docking.
- Master computational tools for drug discovery (e.g., PyRx, Modeller, ArgusLab).
- Perform binding site prediction, molecular docking, and virtual screening.
- Analyze and interpret docking results, pharmacophore modeling, and drug-likeness.
- Apply in silico techniques to real-world preclinical drug development projects.
Lead Instructor
Dr. Sarah Chen
PhD in Computational Mechanics from MIT with 15+ years of experience in Industrial AI. Former Lead Data Scientist at Tesla and current advisor to Fortune 500 manufacturing firms.
Limited SeatsClosing Soon
In Silico Molecular Modeling and Docking in Drug Development
Professional Certification Program
🎥
FormatLive + Recorded
📅
Duration8 Weeks
📜
CertificationVerified